These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26718207)

  • 1. Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.
    Baroni MG; Giorgino F; Pezzino V; Scaroni C; Avogaro A
    J Endocrinol Invest; 2016 Feb; 39(2):235-55. PubMed ID: 26718207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.
    Baroni MG; Giorgino F; Pezzino V; Scaroni C; Avogaro A; ;
    Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):85-102. PubMed ID: 26905474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycometabolic control in acromegalic patients with diabetes: a study of the effects of different treatments for growth hormone excess and for hyperglycemia.
    Cambuli VM; Galdiero M; Mastinu M; Pigliaru F; Auriemma RS; Ciresi A; Pivonello R; Amato M; Giordano C; Mariotti S; Colao A; Baroni MG
    J Endocrinol Invest; 2012 Feb; 35(2):154-9. PubMed ID: 21532330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010".
    Bruno G; De Micheli A; Frontoni S; Monge L;
    Nutr Metab Cardiovasc Dis; 2011 Apr; 21(4):302-14. PubMed ID: 20851582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone deficiency in treated acromegaly and active Cushing's syndrome.
    Formenti AM; Maffezzoni F; Doga M; Mazziotti G; Giustina A
    Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):79-90. PubMed ID: 28477735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Network for the Enhancement of Endocrinology and Oncology Knowledge: a case-based consideration of current practice in Cushing's disease and acromegaly.
    Biller BM; Sheppard M
    Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23 Suppl 1():S1-4. PubMed ID: 20129189
    [No Abstract]   [Full Text] [Related]  

  • 9. Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing's syndrome, acromegaly and neuroendocrine tumours.
    Guarnotta V; Emanuele F; Salzillo R; Bonsangue M; Amato C; Mineo MI; Giordano C
    Front Endocrinol (Lausanne); 2023; 14():1248985. PubMed ID: 37842314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of acromegaly: a current perspective.
    Manjila S; Wu OC; Khan FR; Khan MM; Arafah BM; Selman WR
    Neurosurg Focus; 2010 Oct; 29(4):E14. PubMed ID: 20887124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy for the syndromes of GH excess.
    Arosio M; Cannavò S; Epaminonda P; Ronchi C; Chiodini I; Adda G
    J Endocrinol Invest; 2003; 26(10 Suppl):36-43. PubMed ID: 15497658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acromegaly: an endocrine society clinical practice guideline.
    Katznelson L; Laws ER; Melmed S; Molitch ME; Murad MH; Utz A; Wass JA;
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3933-51. PubMed ID: 25356808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and Emerging Aspects of Diabetes Mellitus in Acromegaly.
    Frara S; Maffezzoni F; Mazziotti G; Giustina A
    Trends Endocrinol Metab; 2016 Jul; 27(7):470-483. PubMed ID: 27229934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective.
    Patel YC; Ezzat S; Chik CL; Rorstad OP; Serri O; Ur E; Wilkins GE
    Clin Invest Med; 2000 Jun; 23(3):172-87. PubMed ID: 10911548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome: review and joint opinion statement by members of the Italian Society for Endocrinology, Italian Society for Neurosurgery, and Italian Society for Neuroradiology.
    Pecori Giraldi F; Cavallo LM; Tortora F; Pivonello R; Colao A; Cappabianca P; Mantero F;
    Neurosurg Focus; 2015 Feb; 38(2):E5. PubMed ID: 25639323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study.
    Tahara S; Murakami M; Kaneko T; Shimatsu A
    Endocr J; 2017 Jul; 64(7):735-747. PubMed ID: 28592706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The medical management of Cushing's syndrome].
    Leal-Cerro A; Soto Moreno A; Mangas MA; León Justel A; Webb S
    Endocrinol Nutr; 2009 Apr; 56(4):187-94. PubMed ID: 19627735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria for cure of acromegaly: a consensus statement.
    Giustina A; Barkan A; Casanueva FF; Cavagnini F; Frohman L; Ho K; Veldhuis J; Wass J; Von Werder K; Melmed S
    J Clin Endocrinol Metab; 2000 Feb; 85(2):526-9. PubMed ID: 10690849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly - evolving strategies.
    Popovic V
    Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():496-500. PubMed ID: 16444181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.